Ensign Peak Advisors, Inc Sarepta Therapeutics, Inc. Transaction History

Ensign Peak Advisors, Inc

$58.8 Billion
Q3 2025

A detailed history of Ensign Peak Advisors, Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 15,893 shares of SRPT stock, worth $298,947. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,893

Previous 26,893 40.9%

Holding current value

$298,947

Previous $1.72 Million 82.17%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$11.93 - $21.97 $131,230 - $241,670	-11,000 Reduced 40.9%	15,893 $306,000
Q1 2025 May 14, 2025	SELL	$63.82 - $127.89 $9.36 Million - $18.7 Million	-146,598 Reduced 84.5%	26,893 $1.72 Million
Q4 2024 Feb 13, 2025	SELL	$104.54 - $137.94 $5.42 Million - $7.15 Million	-51,837 Reduced 23.01%	173,491 $21.1 Million
Q2 2024 Aug 13, 2024	BUY	$113.33 - $163.85 $4.32 Million - $6.24 Million	38,090 Added 20.34%	225,328 $35.6 Million
Q1 2024 May 14, 2024	SELL	$93.7 - $141.53 $673,890 - $1.02 Million	-7,192 Reduced 3.7%	187,238 $24.2 Million

Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $216,401 - $401,103	-3,215 Reduced 1.63%	194,430 $18.7 Million
Q3 2023 Nov 13, 2023	SELL	$102.5 - $123.59 $49,200 - $59,323	-480 Reduced 0.24%	197,645 $24 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $1.15 Million - $1.69 Million	10,780 Added 5.75%	198,125 $22.7 Million
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $4.7 Million - $6.24 Million	39,985 Added 27.13%	187,345 $25.8 Million
Q4 2022 Feb 13, 2023	BUY	$100.86 - $132.13 $1.69 Million - $2.21 Million	16,750 Added 12.82%	147,360 $19.1 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $8.33 Million - $13.1 Million	110,080 Added 536.19%	130,610 $14.4 Million
Q2 2022 Aug 12, 2022	BUY	$62.69 - $88.44 $25,076 - $35,376	400 Added 1.99%	20,530 $1.54 Million
Q4 2021 Feb 11, 2022	BUY	$77.28 - $99.42 $1.56 Million - $2 Million	20,130 New	20,130 $1.81 Million
Q1 2021 May 12, 2021	SELL	$72.25 - $168.95 $1.64 Million - $3.85 Million	-22,766 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$125.56 - $178.74 $847,278 - $1.21 Million	-6,748 Reduced 22.86%	22,766 $3.88 Million
Q3 2020 Nov 12, 2020	BUY	$127.12 - $172.34 $2.91 Million - $3.95 Million	22,901 Added 346.3%	29,514 $4.14 Million
Q2 2020 Aug 12, 2020	BUY	$93.0 - $171.7 $461,001 - $851,116	4,957 Added 299.34%	6,613 $1.06 Million
Q1 2020 May 11, 2020	SELL	$82.38 - $131.64 $94,489 - $150,991	-1,147 Reduced 40.92%	1,656 $162,000
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $214,513 - $380,030	2,803 New	2,803 $362,000

Others Institutions Holding SRPT

# of Institutions

406

Shares Held

83.7M

Call Options Held

5.27M

Put Options Held

5.94M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $1.65B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Sarepta Therapeutics, Inc. Transaction History